CoChat

Obesity: A preventable, treatable, but relapsing disease

De Lorenzo, Antonio, Romano, Lorenzo, Di Renzo, Laura, Di Lorenzo, Nicola, Cenname, Giuseppe, Gualtieri, Paola · 2020 · Nutrition
Cited by 205

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

In 2013, the American Medical Association recognized obesity as a disease, of growing scientific, social, and political interest. In 2016 in the United States, prevalence rates of preobesity and obesity exceeded 60%. In Italy, these rates exceeded 40%. Total costs related to excess weight reached 9.3% of the U.S. gross domestic product, whereas in Italy the total annual cost of diabetes alone was estimated at 20.3 billion euros/y. The expansion of adipose tissue and visceral fat causes compression, joint stress, metabolic disorders, organ dysfunction, and increased mortality. The increase in peripheral and central fat mass is a chronic and potentially reversible process with appropriate diagnosis and treatment. Conversely, fattening can turn into a chronic relapsing form, complicated by comorbidities and cardiovascular events. The increased risk for mortality and morbidity also can affect metabolically healthy obese individuals, if the condition is underestimated, with disease progression. Due to its inaccuracy, body mass index must be replaced with body composition for the diagnosis of obesity. The chances of obesity reversibility are closely linked to improving the diagnosis and to timely nutritional interventions. Generalization and stigma hinder the treatment of obese individuals. The recognition of obesity as a disease and institutional interest can shift the focus onto obesity and not on the obese, with improvements in adherence to prevention plans. Anthropogenic factors and gut microbiota can influence human behavior and food choice, such as food addiction. Obesity has all the criteria to be recognized as a disease. Proper clinical management will lead to cost and complications savings, such as in diabetes. The aim of this review was to discuss in detail the criteria for defining primary obesity as a disease in a step-by-step manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nut.2019.110615

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Demongeot, 2016, Discrete dynamics of contagious social diseases: Example of obesity, Virulence, 7, 129, 10.1080/21505594.2015.1082708 · doi:10.1080/21505594.2015.1082708
  2. Hofmann, 2016, Obesity as a socially defined disease: philosophical considerations and implications for policy and care, Health Care Anal, 24, 86, 10.1007/s10728-015-0291-1 · DOI
  3. 2017, Should we officially recognise obesity as a disease?, Lancet Diabetes Endocrinol, 5, 483, 10.1016/S2213-8587(17)30191-2 · DOI
  4. Żukiewicz-Sobczak, 2014, Obesity and poverty paradox in developed countries, Ann Agric Environ Med, 21, 590, 10.5604/12321966.1120608 · DOI
  5. Daneschvar, 2016, FDA-approved anti-obesity drugs in the United States, Am J Med, 129, 10.1016/j.amjmed.2016.02.009 · DOI · Paper page
  6. Molfino, 2010, Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism, JPEN J Parenter Enteral Nutr, 34, 295, 10.1177/0148607109353440 · DOI
  7. Laviano, 2013, Sarcopenia and chemotherapy dosing in obese patients, Nat Rev Clin Oncol, 10, 664, 10.1038/nrclinonc.2013.108-c1 · DOI
  8. Kim, 2016, Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis, Value Health, 19, 602, 10.1016/j.jval.2016.02.008 · DOI · Paper page
  9. Costa de Miranda, 2018, Secular trend of childhood nutritional status in Calabria (Italy) and the United States: the spread of obesity, Nutr Res, 62, 23, 10.1016/j.nutres.2018.10.008 · DOI
  10. Atella, 2015, Excess body weight increases the burden of age-associated chronic diseases and their associated health care expenditures, Aging (Albany NY), 7, 882, 10.18632/aging.100833 · DOI
  11. De Lorenzo, 2019, Developing and cross-validation of new equations to estimate fat mass in Italian population, Eur Rev Med Pharmacol Sci, 23, 2513
  12. Marcellusi, 2016, The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach, Eur J Health Econ, 17, 139, 10.1007/s10198-014-0660-y · DOI
  13. Correia, 2018, Cost-effectiveness of nutrition therapy, Nutrition, 50, 109, 10.1016/j.nut.2018.01.001 · DOI
  14. Bays, 2008, Is adiposopathy (sick fat) an endocrine disease?, Int J Clin Pract, 62, 1474, 10.1111/j.1742-1241.2008.01848.x · DOI · Paper page
  15. King, 2013, Obesity & osteoarthritis, Indian J Med Res, 138, 185
  16. Ertunc, 2016, Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment, J Lipid Res, 57, 2099, 10.1194/jlr.R066514 · DOI · Paper page
  17. Mendez-Sanchez, 2018, New aspects of lipotoxicity in nonalcoholic steatohepatitis, Int J Mol Sci, 19, E2034, 10.3390/ijms19072034 · DOI · Paper page
  18. Wende, 2012, Mechanisms of lipotoxicity in the cardiovascular system, Curr Hypertens Rep, 14, 517, 10.1007/s11906-012-0307-2 · DOI · Paper page
  19. Halade, 2017, Obesity and cardiometabolic defects in heart failure pathology, Compr Physiol, 7, 1463, 10.1002/j.2040-4603.2017.tb00788.x · doi:10.1002/j.2040-4603.2017.tb00788.x
  20. Psaltopoulou, 2010, The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses, Rev Diabet Stud, 7, 26, 10.1900/RDS.2010.7.26 · DOI · Paper page
  21. Hughes, 2014, Timing of adiposity rebound and adiposity in adolescence, Pediatrics, 134, e1354, 10.1542/peds.2014-1908 · DOI
  22. Koyama, 2014, Adiposity rebound and the development of metabolic syndrome, Pediatrics, 133, e114, 10.1542/peds.2013-0966 · DOI
  23. Hinney, 2010, From monogenic to polygenic obesity: recent advances, Eur Child Adolesc Psychiatry, 19, 297, 10.1007/s00787-010-0096-6 · DOI · Paper page
  24. Mozaffarian, 2018, Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program(SNAP): a microsimulation study, PLoS Med, 15, 10.1371/journal.pmed.1002661 · DOI · Paper page
  25. Petrakis, 2017, Endocrine disruptors leading to obesity and related diseases, Int J Environ Res Public Health, 14, E1282, 10.3390/ijerph14101282 · DOI · Paper page
  26. Wang, 2016, Obesity reduces cognitive and motor functions across the lifespan, Neural Plast, 10.1155/2016/2473081 · DOI · Paper page
  27. Soldati, 2018, The influence of diet on anti-cancer immune responsiveness, J Transl Med, 16, 75, 10.1186/s12967-018-1448-0 · DOI · Paper page
  28. Bouter, 2017, Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction, Gastroenterology, 152, 1671, 10.1053/j.gastro.2016.12.048 · DOI · Paper page
  29. Catalano, 2017, Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child, BMJ, 356, j1, 10.1136/bmj.j1 · DOI · Paper page
  30. Di Renzo, 2018, Influence of FTO rs9939609 and Mediterranean diet on body composition and weight loss: a randomized clinical trial, J Transl Med, 16, 308, 10.1186/s12967-018-1680-7 · DOI · Paper page
  31. Lavebratt, 2012, Epigenetic regulation in obesity, Int J Obes (Lond), 36, 757, 10.1038/ijo.2011.178 · DOI
  32. Godfrey, 2015, The developmental environment, epigenetic biomarkers and long-term health, J Dev Orig Health Dis, 6, 399, 10.1017/S204017441500121X · DOI · Paper page
  33. Hamer, 2019, Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study, Neurology, 92, e594, 10.1212/WNL.0000000000006879 · DOI · Paper page
  34. Geha, 2017, Reorganization of brain connectivity in obesity, Hum Brain Mapp, 38, 1403, 10.1002/hbm.23462 · DOI
  35. Parameswaran, 2006, Altered respiratory physiology in obesity, Can Respir J, 13, 203
  36. Maiolo, 2001, Is altered body fat distribution responsible for reduced pulmonary function in obese type 2 diabetic adult women?, Diabetes Care, 24, 961, 10.2337/diacare.24.5.961 · doi:10.2337/diacare.24.5.961
  37. Bruno, 2009, Dual-energy X-ray absorptiometry analysis of body composition in patients affected by OSAS, Eur Arch Otorhinolaryngol, 266, 1285, 10.1007/s00405-008-0844-0 · DOI
  38. Nam, 2017, Obesity-related digestive diseases and their pathophysiology, Gut Liver, 11, 323, 10.5009/gnl15557 · DOI
  39. Rizzo, 2013, Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome, J Endocrinol Invest, 36, 527
  40. Dolin, 2018, Pregnancy in women with obesity, Obstet Gynecol Clin North Am, 45, 217, 10.1016/j.ogc.2018.01.005 · DOI
  41. Lause, 2017, Dermatologic manifestations of endocrine disorders, Transl Pediatr, 6, 300, 10.21037/tp.2017.09.08 · DOI · Paper page
  42. George, 2016, The obesity epidemic and consequences for rheumatoid arthritis care, Curr Rheumatol Rep, 18, 6, 10.1007/s11926-015-0550-z · DOI · Paper page
  43. Ackerman, 2017, Insights into the link between obesity and cancer, Curr Obes Rep, 6, 195, 10.1007/s13679-017-0263-x · DOI
  44. Kim, 2016, Obesity and cardiovascular disease: friend or foe?, Eur Heart J, 37, 3560, 10.1093/eurheartj/ehv509 · DOI · Paper page
  45. Kovesdy, 2017, Obesity and kidney disease: hidden consequences of the epidemic, Iran J Kidney Dis, 11, 99
  46. Urano, 2015, Recent genetic discoveries in osteoporosis, sarcopenia and obesity, Endocr J, 62, 475, 10.1507/endocrj.EJ15-0154 · DOI · Paper page
  47. Stevens, 2015, Obesity related complications in surgery, Curr Opin Otolaryngol Head Neck Surg, 23, 341, 10.1097/MOO.0000000000000194 · DOI
  48. Damilakis, 2010, Radiation exposure in X-ray-based imaging techniques used in osteoporosis, Eur Radiol, 20, 2707, 10.1007/s00330-010-1845-0 · DOI · Paper page
  49. Baim, 2005, Precision assessment and radiation safety for dualenergy xray absorptiometry: (DXA) white paper of the International Society for Clinical Densitometry, J Clin Densitom (JCD), 8
  50. De Lorenzo, 2006, Normal weight obese (NWO) women: an evaluation of a candidate new syndrome, Nutr Metab Cardiovasc Dis, 16, 513, 10.1016/j.numecd.2005.10.010 · DOI · Paper page
  51. Di Renzo, 2006, Body composition analyses in normal weight obese women, Eur Rev Med Pharmacol Sci, 10, 191
  52. De Lorenzo, 2016, New obesity classification criteria as a tool for bariatric surgery indication, World J Gastroenterol, 22, 681, 10.3748/wjg.v22.i2.681 · DOI · Paper page
  53. Ding, 2016, Lean, but not healthy: the 'metabolically obese, normal-weight' phenotype, Curr Opinions Clin Nutr Metab Care, 19, 408
  54. Di Renzo, 2013, Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome, Dis Markers, 35, 615, 10.1155/2013/983424 · DOI · Paper page
  55. Aung, 2014, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals, J Clin Endocrinol Metab, 99, 462, 10.1210/jc.2013-2832 · DOI · Paper page
  56. Kelly, 2019, Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles, Nutrients, 11, E747, 10.3390/nu11040747 · DOI · Paper page
  57. Nath, 2019, The injustice of fat stigma, Bioethics, 33, 577, 10.1111/bioe.12560 · doi:10.1111/bioe.12560
  58. Martinez, 2018, Toxoplasma gondii infection and behavioral outcomes in humans: a systematic review, Parasitol Res, 117, 3059, 10.1007/s00436-018-6040-2 · DOI
  59. Alcock, 2014, Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms, Bioessays, 36, 940, 10.1002/bies.201400071 · DOI · Paper page
  60. Zhang, 2019, Preventable cancer burden associated with poor diet in the United States, JNCI Cancer Spectrum, pkz034, 10.1093/jncics/pkz034 · DOI · Paper page
  61. Lopez, 2019, Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics, Int J Epidemiol, 10.1093/ije/dyz143 · DOI · Paper page
  62. Pan, 2019, Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal women, Oncotarget, 10, 3088, 10.18632/oncotarget.26864 · DOI
  63. Brenner, 2019, Estimates of the current and future burden of cancer attributable to excess body weight and abdominal adiposity in Canada, Prev Med, 122, 49, 10.1016/j.ypmed.2019.03.014 · DOI

Cited by

See all 205

Metadata

Authors
De Lorenzo, A., Romano, L., Di Renzo, L., Di Lorenzo, N., Cenname, G., & Gualtieri, P.
Venue
Nutrition
Publisher
Elsevier BV
Published
2020-03
Volume
71
Pages
110615
ISSN
0899-9007 (ISSN-L)
OpenAlex
W2980456360
Cited by
205
References
8
FWCI
36.14
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.